Roivant Sciences LtdNASDAQ:ROIV
- LAST PRICE8.5400
- TODAY'S CHANGE (%)0.2400 (2.8916%)
- Bid / Lots8.1300/ 1
- Ask / Lots8.2500/ 1
- Open / Previous Close8.3300 / 8.3000
- Day Range
- 52 Week Range
- Volume1,468,527
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ROIV |
|---|---|---|
| 09:32 ET | 16586 | 8.39 |
| 09:33 ET | 1701 | 8.41 |
| 09:35 ET | 4199 | 8.39 |
| 09:37 ET | 5140 | 8.35 |
| 09:39 ET | 2800 | 8.4 |
| 09:42 ET | 4900 | 8.41 |
| 09:44 ET | 5540 | 8.44 |
| 09:46 ET | 7200 | 8.44 |
| 09:48 ET | 4600 | 8.41 |
| 09:50 ET | 2600 | 8.43 |
| 09:51 ET | 1700 | 8.43 |
| 09:53 ET | 1750 | 8.435 |
| 09:55 ET | 4900 | 8.44 |
| 09:57 ET | 2711 | 8.47 |
| 10:00 ET | 1500 | 8.4624 |
| 10:02 ET | 3782 | 8.42 |
| 10:04 ET | 4572 | 8.38 |
| 10:06 ET | 1200 | 8.385 |
| 10:08 ET | 3518 | 8.38 |
| 10:09 ET | 5000 | 8.4 |
| 10:11 ET | 10292 | 8.4 |
| 10:13 ET | 3366 | 8.42 |
| 10:15 ET | 2313 | 8.465 |
| 10:18 ET | 7176 | 8.44 |
| 10:20 ET | 2654 | 8.45 |
| 10:22 ET | 221 | 8.46 |
| 10:24 ET | 2931 | 8.45 |
| 10:26 ET | 1502 | 8.46 |
| 10:27 ET | 200 | 8.465 |
| 10:29 ET | 2200 | 8.45 |
| 10:31 ET | 3806 | 8.46 |
| 10:33 ET | 1615 | 8.465 |
| 10:36 ET | 6960 | 8.455 |
| 10:38 ET | 4100 | 8.46 |
| 10:40 ET | 3400 | 8.445 |
| 10:42 ET | 1552 | 8.46 |
| 10:44 ET | 3936 | 8.425 |
| 10:45 ET | 1405 | 8.415 |
| 10:47 ET | 4278 | 8.415 |
| 10:49 ET | 2959 | 8.435 |
| 10:51 ET | 4813 | 8.44 |
| 10:54 ET | 901 | 8.445 |
| 10:56 ET | 4428 | 8.435 |
| 10:58 ET | 2778 | 8.44 |
| 11:00 ET | 8778 | 8.415 |
| 11:02 ET | 2903 | 8.43 |
| 11:03 ET | 6169 | 8.425 |
| 11:05 ET | 4306 | 8.425 |
| 11:07 ET | 1800 | 8.42 |
| 11:09 ET | 4248 | 8.425 |
| 11:12 ET | 1575 | 8.435 |
| 11:14 ET | 800 | 8.44 |
| 11:16 ET | 17093 | 8.455 |
| 11:18 ET | 4534 | 8.445 |
| 11:20 ET | 5533 | 8.445 |
| 11:21 ET | 12758 | 8.41 |
| 11:23 ET | 2000 | 8.405 |
| 11:25 ET | 6962 | 8.405 |
| 11:27 ET | 7272 | 8.375 |
| 11:30 ET | 3059 | 8.405 |
| 11:32 ET | 2052 | 8.41 |
| 11:34 ET | 2780 | 8.395 |
| 11:36 ET | 1800 | 8.405 |
| 11:38 ET | 2446 | 8.375 |
| 11:39 ET | 2072 | 8.37 |
| 11:41 ET | 1787 | 8.38 |
| 11:43 ET | 8322 | 8.4 |
| 11:45 ET | 3800 | 8.4 |
| 11:48 ET | 2100 | 8.405 |
| 11:50 ET | 2010 | 8.405 |
| 11:52 ET | 1913 | 8.395 |
| 11:54 ET | 756 | 8.395 |
| 11:56 ET | 2535 | 8.39 |
| 11:57 ET | 800 | 8.39 |
| 11:59 ET | 800 | 8.385 |
| 12:01 ET | 556 | 8.395 |
| 12:03 ET | 6101 | 8.385 |
| 12:06 ET | 14308 | 8.375 |
| 12:08 ET | 3329 | 8.385 |
| 12:10 ET | 1600 | 8.38 |
| 12:12 ET | 1200 | 8.375 |
| 12:14 ET | 1400 | 8.385 |
| 12:15 ET | 500 | 8.39 |
| 12:17 ET | 3525 | 8.375 |
| 12:19 ET | 4731 | 8.36 |
| 12:21 ET | 1000 | 8.365 |
| 12:24 ET | 1897 | 8.36 |
| 12:26 ET | 200 | 8.355 |
| 12:28 ET | 800 | 8.36 |
| 12:30 ET | 3040 | 8.335 |
| 12:32 ET | 2000 | 8.325 |
| 12:33 ET | 100 | 8.325 |
| 12:35 ET | 9011 | 8.325 |
| 12:37 ET | 1700 | 8.34 |
| 12:39 ET | 905 | 8.365 |
| 12:42 ET | 4119 | 8.37 |
| 12:44 ET | 7338 | 8.385 |
| 12:46 ET | 6490 | 8.38 |
| 12:48 ET | 100 | 8.38 |
| 12:50 ET | 2700 | 8.395 |
| 12:51 ET | 400 | 8.395 |
| 12:53 ET | 3281 | 8.395 |
| 12:55 ET | 300 | 8.395 |
| 12:57 ET | 1500 | 8.405 |
| 01:00 ET | 4396 | 8.395 |
| 01:02 ET | 7079 | 8.385 |
| 01:04 ET | 11767 | 8.395 |
| 01:06 ET | 1700 | 8.395 |
| 01:08 ET | 3482 | 8.405 |
| 01:09 ET | 3348 | 8.395 |
| 01:11 ET | 3848 | 8.405 |
| 01:13 ET | 673 | 8.405 |
| 01:15 ET | 8731 | 8.415 |
| 01:18 ET | 400 | 8.415 |
| 01:20 ET | 1043 | 8.425 |
| 01:22 ET | 4985 | 8.435 |
| 01:24 ET | 19029 | 8.42 |
| 01:26 ET | 1100 | 8.435 |
| 01:27 ET | 1900 | 8.435 |
| 01:29 ET | 5909 | 8.43 |
| 01:31 ET | 1800 | 8.435 |
| 01:33 ET | 3398 | 8.41 |
| 01:36 ET | 600 | 8.415 |
| 01:38 ET | 20834 | 8.405 |
| 01:40 ET | 1800 | 8.405 |
| 01:42 ET | 600 | 8.405 |
| 01:44 ET | 3886 | 8.395 |
| 01:45 ET | 5400 | 8.395 |
| 01:47 ET | 11174 | 8.385 |
| 01:49 ET | 2400 | 8.38 |
| 01:51 ET | 4948 | 8.375 |
| 01:54 ET | 2100 | 8.375 |
| 01:56 ET | 13573 | 8.395 |
| 01:58 ET | 1595 | 8.4 |
| 02:00 ET | 3462 | 8.395 |
| 02:02 ET | 9618 | 8.42 |
| 02:03 ET | 2579 | 8.44 |
| 02:05 ET | 14680 | 8.45 |
| 02:07 ET | 4300 | 8.45 |
| 02:09 ET | 2462 | 8.47 |
| 02:12 ET | 12139 | 8.5 |
| 02:14 ET | 2449 | 8.505 |
| 02:16 ET | 3595 | 8.505 |
| 02:18 ET | 3110 | 8.495 |
| 02:20 ET | 3598 | 8.5 |
| 02:21 ET | 3000 | 8.505 |
| 02:23 ET | 2759 | 8.485 |
| 02:25 ET | 4549 | 8.49 |
| 02:27 ET | 1888 | 8.49 |
| 02:30 ET | 4483 | 8.48 |
| 02:32 ET | 5538 | 8.46 |
| 02:34 ET | 3299 | 8.465 |
| 02:36 ET | 3465 | 8.475 |
| 02:38 ET | 4336 | 8.5 |
| 02:39 ET | 12184 | 8.52 |
| 02:41 ET | 6258 | 8.56 |
| 02:43 ET | 10129 | 8.59 |
| 02:45 ET | 4881 | 8.605 |
| 02:48 ET | 5706 | 8.615 |
| 02:50 ET | 1485 | 8.615 |
| 02:52 ET | 9148 | 8.595 |
| 02:54 ET | 5013 | 8.605 |
| 02:56 ET | 5835 | 8.6 |
| 02:57 ET | 3098 | 8.575 |
| 02:59 ET | 3077 | 8.585 |
| 03:01 ET | 1100 | 8.595 |
| 03:03 ET | 1571 | 8.605 |
| 03:06 ET | 4771 | 8.615 |
| 03:08 ET | 7677 | 8.61 |
| 03:10 ET | 4340 | 8.615 |
| 03:12 ET | 5242 | 8.605 |
| 03:14 ET | 6004 | 8.585 |
| 03:15 ET | 3726 | 8.565 |
| 03:17 ET | 4000 | 8.555 |
| 03:19 ET | 3668 | 8.595 |
| 03:21 ET | 3677 | 8.595 |
| 03:24 ET | 4008 | 8.57 |
| 03:26 ET | 4997 | 8.585 |
| 03:28 ET | 2100 | 8.575 |
| 03:30 ET | 3492 | 8.575 |
| 03:32 ET | 3950 | 8.5705 |
| 03:33 ET | 7079 | 8.58 |
| 03:35 ET | 8674 | 8.605 |
| 03:37 ET | 8860 | 8.6 |
| 03:39 ET | 8306 | 8.575 |
| 03:42 ET | 2300 | 8.57 |
| 03:44 ET | 9541 | 8.565 |
| 03:46 ET | 12902 | 8.56 |
| 03:48 ET | 9482 | 8.54 |
| 03:50 ET | 24675 | 8.545 |
| 03:51 ET | 26883 | 8.555 |
| 03:53 ET | 30410 | 8.545 |
| 03:55 ET | 33123 | 8.55 |
| 03:57 ET | 31807 | 8.55 |
| 04:00 ET | 82960 | 8.54 |
Today
BRIEF-Roivant Sciences Provides An Update On Its Financial Results For The Third Quarter , from 2 hours ago by Thomson Reuters
2 hours ago by Thomson ReutersBRIEF-Roivant Sciences Announces Proposed Public Offering Of Common Shares, from 3 hours ago by Thomson Reuters
3 hours ago by Thomson ReutersRoivant Sciences Announces Proposed Public Offering of Common Shares, from 5 hours ago by GlobeNewswire
5 hours ago by GlobeNewswire
Jan 30, 2023
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023, from 8:00AM ET on Monday Jan 30, 2023 by GlobeNewswire
8:00AM ET on Monday Jan 30, 2023 by GlobeNewswire
Jan 19, 2023
Goldman Sachs Adjusts Price Target on Roivant Sciences to $11 From $10, Maintains Buy Rating, from 10:06AM ET on Thursday Jan 19, 2023 by MT Newswires
10:06AM ET on Thursday Jan 19, 2023 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Roivant Sciences Ltd | 6.0B | -5.0x | --- |
Apellis Pharmaceuticals Inc | 5.8B | -8.8x | --- |
Cerevel Therapeutics Holdings Inc | 5.3B | -16.4x | --- |
Karuna Therapeutics Inc | 6.9B | -26.1x | --- |
Prometheus Biosciences Inc | 5.3B | -32.7x | --- |
Madrigal Pharmaceuticals Inc | 4.9B | -18.0x | --- |
Company Information
Roivant Sciences Ltd. is a pharma company. The Company is focused on developing transformative medicines that address areas of unmet medical need. The Company, through its subsidiaries, is focused on delivering medicines and technologies to patients. The Company builds biotech and healthcare technology companies (Vants) and deploys technology to drive research and development and commercialization. The Company’s product candidate includes VTAMA (tapinarof), IMVT-1401, Brepocitinib, Namilumab and RVT-2001. Its Vant family includes Dermavant, Immunovant, Priovant, Kinevant and Hemavant. Its small molecule discovery engine is powered by computational physics and machine learning (ML) capabilities for in silico drug design. The Company’s capabilities in diverse therapeutic areas, including immunology, dermatology and oncology, and modalities, including biologics, topicals and bifunctional small molecules.
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, Bermuda HM11
- Phone
- ---
- Fax
- ---
Executives
- Executive Chairman of the Board, Founder
- Vivek Ramaswamy
- President, Chief Operating Officer
- Eric Venker
- President, Chief Investment Officer
- Mayukh Sukhatme
- Chief Executive Officer, Director
- Matthew Gline
- Chief Financial Officer
- Richard Pulik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.0B |
|---|---|
Revenue (TTM) | $50.4M |
Shares Outstanding | 725.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.70 |
Book Value | $2.38 |
P/E Ratio | -5.0x |
Price/Sales (TTM) | 119.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,090.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
